Peter Rankin

Peter Rankin

Vice President

Peter Rankin specializes in the economic and strategic evaluation of the pharmaceutical and health care industries. Dr. Rankin’s pharmaceutical research includes assessment of patent extension antitrust claims, class certification analysis, monetary damages from intellectual property disputes, evaluation of blood/plasma market dynamics, product line valuation, and product reimbursement strategies. His health industry research includes analysis of attempted monopolization, demand for medical services, and the cost implications of antitrust waivers for health care providers.

While a doctoral candidate at Duke University, Dr. Rankin was researcher at the Center for Health Policy, Law, and Management, where he published papers on hospital conversions; medical malpractice; and managed care quality, satisfaction, and participation. His dissertation research evaluates pricing and product differentiation in the Medicare managed care market.

Education

PhD, Economics, Duke University
MA, Economics, Duke University
BA, Politics, Philosophy & Economics, Claremont McKenna College

Dr. Rankin is a pharmaceutical, life sciences, and health care industry expert. His pharma and health care expertise spans a wide variety of antitrust and competition economics litigation.